Skip to main content
Premium Trial:

Request an Annual Quote

Expression Analysis Teams with Illumina, Golden Helix on Grant Program

Premium

Expression Analysis announced yesterday that it has teamed up with Illumina and Golden Helix on an RNA-seq grant program.

Under the program, Expression Analysis will perform the sequencing and provide primary and secondary data analysis, while Golden Helix will provide cloud-based secondary analysis tools and storage as well as end-user tertiary analysis tools. Illumina will provide the products for the studies, Expression Analysis said.

One grant will be awarded for each category: biomarker discovery using whole-transcriptome sequencing; developmental coding and non-coding RNA expression; and RNA-seq analysis of FFPE samples.

Applications for the grants are due April 13, and recipients will be notified no later than May 15. More information about the grant program can be found on Expression Analysis' website.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.